A ROCK inhibitor, fasudil, prevents behavioral changes induced by social defeat stress in mice

DOI Web Site
  • Nakatake Yuko
    Laboratory of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Tokyo University of Science Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry
  • Yamada Misa
    Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry
  • Furuie Hiroki
    Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry
  • Yoshizawa Kazumi
    Laboratory of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Tokyo University of Science
  • Yamada Mitsuhiko
    Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry

Bibliographic Information

Other Title
  • ROCK阻害剤であるファスジルは社会的敗北ストレスによるマウスの行動変化を予防する

Abstract

<p>Previously, we reported that expression of Rho/Rho-associated kinase (Rho/ROCK) pathway related genes in the rat brain were decreased after chronic administration of antidepressants, imipramine and sertraline. Then, we hypothesized that inhibition of ROCK would serve as a medication to treat stress-related mental disorders. In this study, we investigated the effect of a ROCK inhibitor, fasudil, using social defeat stress (SDS) mouse, which is considered as an animal model of stress-related mental disorders. As expected, SDS mice showed significant increase in the immobility compared with control mice in forced swim test. Interestingly, administration of fasudil during the stress exposure significantly decreased the immobility, while no significant effect was observed in SDS mice treated with fasudil after the stress exposure. Our results may suggest that fasudil would serve as a preventive medication for stress-related mental disorders. Since fasudil has already been used clinically for the treatment of cerebral vasospasm, clinical trials to examine the efficacy of fasudil in patients with stress-related mental disorders are warranted.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top